Venture capital (VC) firm HongShan, previously known as Sequoia Capital China, has closed a new RMB-denominated fund at about 18 billion yuan ($2.5 billion) to continue its investment focus on the technology, healthcare, and consumer sectors.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com